Stanker James H 4
4 · Processa Pharmaceuticals, Inc. · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Stanker James H
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2022-12-31−12,951→ 352,614 totalExercise: $0.00→ Common Stock (12,951 underlying) - Award
Restricted Stock Units
2023-01-01−69,667→ 422,281 totalExercise: $0.00→ Common Stock (69,667 underlying) - Award
Restricted Stock Units
2023-01-01−96,150→ 518,431 totalExercise: $0.00→ Common Stock (96,150 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death. These restricted stock units vest on date grant.
- [F2]Each restricted stock units represents a contingent right to receive one share of the lssuers common stock, following its vesting on 01/01/24, upon the earlier of termination of employment; the third anniversary of the award date; a change in control, or the reporting persons death.
- [F3]Each restricted stock units represents a contingent right to receive one share of the Issuers common stock, following its vesting of one-third on 01/01/24; 01/01/25 and 01/01/26, upon the earlier of termination of employment; the third anniversary of the award date; a change in control, or the reporting persons death.